Related Experiment Videos
Cefotaxime desensitization
G Papakonstantinou1, J R Bogner, F Hofmeister
1III Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg.
The Clinical Investigator
|February 1, 1993
Summary
This study details successful cefotaxime desensitization in a patient with severe osteomyelitis and drug hypersensitivity. This approach may benefit patients with severe infections when alternative antibiotics are unsuitable.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Severe lumbar osteomyelitis of unknown bacteriology presented a treatment challenge.
- The patient exhibited hypersensitivity to cefotaxime, necessitating an alternative therapeutic strategy.
- Alternative antibiotic options were limited, making cefotaxime desensitization a viable consideration.
Observation:
- A gradual intravenous cefotaxime (cefotaxime) administration protocol was initiated.
- The daily dosage was incrementally increased over 13 days, reaching 4 g.
- The patient was monitored for allergic reactions during and after the desensitization process.
Findings:
- Successful desensitization to cefotaxime was achieved without any allergic reactions.
- The patient tolerated the full therapeutic dose of cefotaxime throughout the observation period.
- No adverse events were noted during the 4-week follow-up.
Implications:
- Cefotaxime desensitization can be a safe and effective option for patients with severe infections and antibiotic hypersensitivity.
- This strategy is particularly relevant when the causative pathogen is unknown and alternative treatments are unavailable.
- Consideration of antibiotic desensitization may expand therapeutic options in complex infectious disease cases.